Bullish on Lupin and Sun Pharma: Kunj Bansal
"If one is looking at pure momentum, then Lupin and Sun Pharma will continue to do well."
By 
| Updated:
| Updated: In a chat with ET Now, Kunj Bansal, CIO, Sanlam India, shares his views on various pharma stocks.
ET Now: What is your call on Lupin and Sun Pharma?
Kunj Bansal: If one is looking at pure momentum and market sustaining, then Lupin and Sun Pharma are the names which will continue to do well.
ET Now: What is your call on Lupin and Sun Pharma?
Kunj Bansal: If one is looking at pure momentum and market sustaining, then Lupin and Sun Pharma are the names which will continue to do well.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Valuation gap between PSU and private banks to reduce further: Kunj BansalADVERTISEMENT
